🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I, first-in-human dose-escalation study was conducted to determi...
Status
Completed
Location
Guangdong General Hospital
Start Date
2016-04
Trial ID
NCT02896231
Treatments Being Tested
To assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC...
Status
Recruiting
Location
Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute
Start Date
2017-09-27
Trial ID
NCT03175224
Treatments Being Tested
Efficacy and Safety Evaluation of Vebreltinib Plus PLB1004 as the First-lin...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-08-07
Trial ID
NCT06574347
Treatments Being Tested
This is a Phase 1, open-label, multi-center, randomized, 2-period, adaptive...
Status
Unknown
Location
New Zealand Clinical Research
Start Date
2022-05-20
Trial ID
NCT05367388
This is a Prospective, open label, single arm study to evaluate the efficac...
Status
Active Not Recruiting
Location
Cancer insititue and Hospital of CHINESE ACADEMY OF MEDICAL SCIENCE
Start Date
2024-10-14
Trial ID
NCT06827145
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and efficacy of P...
Status
Active Not Recruiting
Location
Beijing Tiantan Hospital,Capital Medical University
Start Date
2018-10-08
Trial ID
NCT06105619
Treatments Being Tested
Efficacy and Safety of Vebreltinib in Combination With PLB1004 Versus Plati...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-15
Trial ID
NCT06970782
Treatments Being Tested
The goal of this clinical trial is to test if PLB1001 works well and safely...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2023-10-16
Trial ID
NCT05989542
Treatments Being Tested
This phase I, open-label, dose-escalation study was conducted to determine ...
Status
Completed
Location
Beijing Shijitan Hospital,CMU
Start Date
2016-09
Trial ID
NCT02978261
Treatments Being Tested
This is a Phase II, open-label, multicenter and multi-cohorts study of PLB1...
Status
Completed
Location
Guangdong General Hospital
Start Date
2020-01-17
Trial ID
NCT04258033
Treatments Being Tested